These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3123483)

  • 1. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
    Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
    J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA; Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
    J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA; Hamel NM
    J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
    Wagner OF; Vetterlein M; Binder BR
    J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
    Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
    Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM; Loskutoff DJ
    Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
    Ramsby ML; Kreutzer DL
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
    Fukao H; Ueshima S; Tanaka N; Okada K; Matsuo O
    Thromb Res Suppl; 1990; 10():11-20. PubMed ID: 2107596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
    Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
    Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
    Mimuro J; Loskutoff DJ
    J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
    Fukushima M; Nakashima Y; Sueishi K
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1576-83. PubMed ID: 2501229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.
    Bartha K; Declerck PJ; Moreau H; Nelles L; Collen D
    J Biol Chem; 1991 Jan; 266(2):792-7. PubMed ID: 1898737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.
    Levin EG; Santell L
    Blood; 1987 Oct; 70(4):1090-8. PubMed ID: 3498518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
    Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture.
    Shatos MA; Doherty JM; Stump DC; Thompson EA; Collen D
    J Biol Chem; 1990 Nov; 265(33):20443-8. PubMed ID: 2122975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.